Tag: Pancreas

Search News
Categories
Archives
Antibody therapy in pancreatic cancer

31st July 2019

Scientists have found a way to target and knock out a single protein that they have discovered is widely involved in pancreatic cancer cell growth, survival and invasion. Called avb6, the protein is present on the surface of more than 80 per cent of pancreatic ductal adenocarcinoma – the most common form of pancreatic cancer – and is vital to increase the successful growth and spread of the tumour cells.

Read more

New research funded by PCRF

19th July 2019

The Pancreatic Cancer Research Fund is supporting two new research projects at the Barts Cancer Institute, Queen Mary University of London. The projects, led by Professor Hemant Kocher and Dr Gunnel Halldén, will aim to identify ways to enhance the efficacy of treatments for pancreatic cancer, to ultimately help those affected by this devastating disease.

Read more

Tackling tumour scar tissue could be key to treating pancreatic cancer

11th February 2019

The first study in the world to take a detailed look at scar tissue in human pancreatic cancer has revealed a range of different scar tissue types that could help clinicians predict which patients will respond best to particular treatments.

Read more

Pancreatic Cancer Awareness Month 2018

26th November 2018

November marks Pancreatic Cancer Awareness Month. Pancreatic cancer is diagnosed in over 9,900 people in the UK annually.

Read more

‘The neighbouring effect’: Centrosomal abnormalities drive invasion of surrounding cells

19th November 2018

Centrosomal amplification, a particular change that occurs within some cancer cells, has been shown to drive the invasion of neighbouring cancer cells.

Read more

Pancreatic Cancer UK Grand Challenge

27th July 2018

Our Director, Prof Nicholas Lemoine, and a team of researchers from the BCI and King’s College London have been awarded the Pancreatic Cancer UK (PCUK) Grand Challenge- PCUK’s largest ever research fund. The grant will be used for the development of a type of immunotherapy, known as CAR T cell therapy, to treat pancreatic cancer. Leanne Reynolds, Head of Research at PCUK […]

Read more

Search News
Categories
Archives